The proteolytic stability of 'designed' β-peptides containing α-peptide-bond mimics and of mixed α,β-peptides:: Application to the construction of MHC-binding peptides

被引:112
作者
Hook, DF [1 ]
Bindschädler, P [1 ]
Mahajan, YR [1 ]
Sebesta, R [1 ]
Kast, P [1 ]
Seebach, D [1 ]
机构
[1] ETH Honggerberg, Eidgenossischen Tech Hsch, Organ Chem Lab, Dept Chem & Angew Biowissensch, CH-8093 Zurich, Switzerland
关键词
D O I
10.1002/cbdv.200590039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Whereas a-peptides are rapidly degraded in vivo and in vitro by a multitude of peptidases, substrates constructed entirely of or incorporating homologated alpha-amino acid (i.e., beta-amino acid) units exhibit a superior stability profile. Efforts made so far to protcolytically hydrolyze a beta-beta peptide bond have not proved fruitful; a study aimed at breaching this proteolytic stability is discussed here. A series of such bonds have been designed with side-chain groups similar in relative positions (constitution) and three-dimensional arrangements (configuration) as found about alpha-peptidic amide bonds. Increasing the prospect for degradation would permit the tuning of beta-peptide stability; here, however, no cleavage was observed (1, 2, 4 - 6, Table 1). Peptides comprised of alpha- and beta-amino acids (mixed alpha,beta-peptides, 8-11) are expected to benefit from both recognition by a natural receptor and a high level of proteolytic stability, ideal characteristics of pharmacologically active compounds. beta(3)-Peptides containing alpha-amino acid moieties at the N-terminus are degraded, albeit slowly, by several peptidases. Of particular interest is the ability of pronase to cleave an alpha-beta peptide bond, namely that of alpha Ala-beta(3)hAla. Significantly, successful hydrolysis is independent of the configuration of the beta-amino acid. Some of the alpha,beta-peptides discussed here are being investigated for their binding affinities to class I MHC proteins. The computer-programming steps required to prepare alpha,beta-peptides on an automated peptide synthesizer are presented.
引用
收藏
页码:591 / 632
页数:42
相关论文
共 91 条
[1]  
ABDERHALDEN E, 1928, FERMENTFORSCHUNG, V10, P195
[2]  
ABDERHALDEN EMIL, 1928, FERMENTFORSCHUNG, V10, P173
[3]   Converting a peptide into a drug: Strategies to improve stability and bioavailability [J].
Adessi, C ;
Soto, C .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (09) :963-978
[4]   The role of HLA-B27 in spondyloarthritis [J].
Allen, RL ;
Bowness, P ;
McMichael, AJ .
IMMUNOGENETICS, 1999, 50 (3-4) :220-227
[5]  
[Anonymous], 2000, FMOC SOLID PHASE PEP
[6]   Non-protein amino acids in peptide design [J].
S. Aravinda ;
N. Shamala ;
Rituparna S. Roy ;
P Balaram .
Journal of Chemical Sciences, 2003, 115 (5-6) :373-400
[7]   Exploring the antibacterial and hemolytic activity of shorter- and longer-chain β- α,β-, and γ-peptides, and of β-peptides from β2-3-aza- and β3-2-methylidene-amino acids bearing proteinogenic side chains -: A survey [J].
Arvidsson, PI ;
Ryder, NS ;
Weiss, HM ;
Hook, DF ;
Escalante, J ;
Seebach, D .
CHEMISTRY & BIODIVERSITY, 2005, 2 (03) :401-420
[8]  
BARRETT AJ, 2004, HDB PROTEOLYTIC ENZY
[9]   Beyond de novo protein design -: de novo design of non-natural folded oligomers [J].
Cheng, RP .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (04) :512-520
[10]   β-peptides:: From structure to function [J].
Cheng, RP ;
Gellman, SH ;
DeGrado, WF .
CHEMICAL REVIEWS, 2001, 101 (10) :3219-3232